Temaz and Amrix drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Temaz (temazepam) and Amrix (cyclobenzaprine hydrochloride). Common drug interactions include injury among females and anaemia among males.

The phase IV clinical study analyzes what interactions people have when they take Temaz and Amrix. It is created by eHealthMe based on reports of 22 people who take the same drugs from the FDA, and is updated regularly.

What is Temaz?

Temaz has active ingredients of temazepam. It is often used in insomnia. eHealthMe is studying from 42,293 Temaz users. Check the latest studies of Temaz.

What is Amrix?

Amrix has active ingredients of cyclobenzaprine hydrochloride. It is often used in back pain. eHealthMe is studying from 1,130 Amrix users. Check the latest studies of Amrix.



On Jul, 13, 2026

22 people who take Temaz and Amrix together, and have interactions are studied.

Temaz and Amrix drug interactions.

What are the common drug interactions of Temaz and Amrix, by gender? *:

female:

  1. Injury
  2. Ligament sprain (ligament stretched)
  3. Limb injury
  4. Lymphoedema (localized fluid retention and tissue swelling)
  5. Malaise (a feeling of general discomfort or uneasiness)
  6. Mitral valve incompetence (inefficient heart valve)
  7. Mood disorder due to a general medical condition
  8. Aphonia (inability to produce voice)
  9. Agitation (state of anxiety or nervous excitement)
  10. Drooling (drop saliva uncontrollably from the mouth)

male:

  1. Anaemia (lack of blood)
  2. Aspartate aminotransferase increased
  3. Neuropathy peripheral (surface nerve damage)
  4. Overdose
  5. Urinary tract infection
  6. Wound dehiscence (a surgical incision reopens either internally or externally)
  7. Colon adenoma (non cancerous epithelial colon tumour having a glandular origin and structure)
  8. Dehydration (dryness resulting from the removal of water)
  9. Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters)
  10. Gastrointestinal haemorrhage (bleeding gastrointestinal tract)

What are the common drug interactions of Temaz and Amrix, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Drug dependence

30-39:

n/a

40-49:

  1. Weight decreased
  2. Abdominal pain upper
  3. Adrenal insufficiency (a condition in which the adrenal glands do not produce adequate amounts of steroids)
  4. Alopecia (absence of hair from areas of the body)
  5. Aphasia (damage to the parts of the brain that control language)
  6. Asthenia (weakness)
  7. Balance disorder
  8. Bladder prolapse (bulging of one or more of the pelvic organs into the vagina)
  9. Dizziness
  10. Fatigue (feeling of tiredness)

50-59:

  1. Chronic kidney disease
  2. Gastric cancer (stomach cancer)
  3. Metastases to liver (cancer spreads to liver)
  4. Metastases to lung (cancer spreads to lung)
  5. Renal failure (kidney dysfunction)
  6. Renal injury (kidney injury)
  7. Abdominal adhesions (inflammation of abdomen)
  8. Affective disorder (mental disorder)
  9. Agitation (state of anxiety or nervous excitement)
  10. Anaemia (lack of blood)

60+:

  1. Cellulitis (infection under the skin)
  2. Erythema of eyelid (redness of the eyelid)
  3. Peripheral swelling
  4. Wound dehiscence (a surgical incision reopens either internally or externally)
  5. Extrasystoles
  6. Eyelid oedema (eyelids are swollen and contain excessive fluid)
  7. Fatigue (feeling of tiredness)
  8. Hot flush (sudden feelings of heat)
  9. Influenza like illness
  10. Knee arthroplasty

What are the existing conditions these people have? *

  1. Pain: 7 people, 31.82%
  2. High Blood Pressure: 5 people, 22.73%
  3. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 5 people, 22.73%
  4. Muscle Spasms (muscle contraction): 5 people, 22.73%
  5. Cardiac Disorder: 4 people, 18.18%
  6. Asthma: 4 people, 18.18%
  7. Fibromyalgia (a long-term condition which causes pain all over the body): 4 people, 18.18%
  8. Hypersensitivity: 4 people, 18.18%
  9. Stress And Anxiety: 3 people, 13.64%
  10. High Blood Cholesterol: 3 people, 13.64%

* Approximation only. Some reports may have incomplete information.

Do you take Temaz and Amrix?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Temaz and Amrix:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Temaz:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Amrix:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Temaz and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Amrix and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on temazepam and cyclobenzaprine hydrochloride (the active ingredients of Temaz and Amrix, respectively), and Temaz and Amrix (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: